Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT03936153

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
View all 23 locations
View Trial Details
Recruiting

AGMT Austrian Lymphoma Registry

NCT06294652

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Universitätsklinik für Innere Medizin III, PMU Salzburg Salzburg, State of Salzburg, Austria
View Trial Details
Recruiting

AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry

NCT06250465

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Landeskrankenhaus Feldkirch, Innere Med. II, Interne E Feldkirch, Austria
  • Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken Innsbruck, Austria
  • A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie Kufstein, Austria
  • KUK Linz: Klinik für Interne 3 - Schwerpunkt Hämatologie und Onkologie Linz, Austria
View Trial Details
Recruiting

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

NCT05945524

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHU d'Amiens Amiens, France
  • CHU de Caen Caen, France
  • Polyclinique du Parc Drevon Dijon, France
  • CH Annecy Genevois Epagny Metz- Tessy, France
View all 18 locations
View Trial Details
Recruiting

Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

NCT06918912

Conditions
B-Cell Lymphoma Treatment, Diffuse Large B-cell Lymphoma, Disease Attributes, +16 more
Locations
  • Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, ALESSANDRIA, Italy
  • Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola Bologna, BO, Italy
  • Azienda Sanitaria Ospedaliera Santa Croce e Carle di Cuneo Cuneo, Italy
  • Ospedale San Raffaele Milan, MILANO, Italy
View Trial Details

Related conditions